|Year : 2015 | Volume
| Issue : 4 | Page : 258-263
Risk factors and hospitalization costs of Dementia patients: Examining race and gender variations
Baqar Husaini1, Aashrai S V Gudlavalleti2, Van Cain1, Robert Levine3, Majaz Moonis2
1 Center for Prevention Research, Tennessee State University, Nashville, Tennessee, USA
2 Department of Neurology, University of Massachusetts, Massachusetts, USA
3 Department of Preventive and Family Medicine, Meharry Medical College, Nashville, Tennessee, USA
|Date of Submission||18-May-2015|
|Date of Acceptance||01-Jul-2015|
|Date of Web Publication||3-Sep-2015|
Center for Prevention Research, Tennessee State University, Nashville, Tennessee
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Aims: To examine the variation in risk factors and hospitalization costs among four elderly dementia cohorts by race and gender. Materials and Methods: The 2008 Tennessee Hospital Discharged database was examined. The prevalence, risk factors and cost of inpatient care of dementia were examined for individuals aged 65 years and above, across the four race gender cohorts - white males (WM), black males (BM), white females (WF), and black females (BF). Results: 3.6% of patients hospitalized in 2008 had dementia. Dementia was higher among females than males, and higher among blacks than whites. Further, BF had higher prevalence of dementia than WF; similarly, BM had a higher prevalence of dementia than WM. Overall, six risk factors were associated with dementia for the entire sample including HTN, DM, CKD, CHF, COPD, and stroke. These risk factors varied slightly in predicting dementia by race and gender. Hospital costs were 14% higher among dementia patients compared to non-dementia patients. Conclusions: There exist significant race and gender disparities in prevalence of dementia. A greater degree of co-morbidity, increased duration of hospital stay, and more frequent hospitalizations, may result in a higher cost of inpatient dementia care. Aggressive management of risk factors may subsequently reduce stroke and cost of dementia care, especially in the black population. Race and gender dependent milestones for management of these risk factors should be considered.
Keywords: Cost, dementia, race-gender cohort
|How to cite this article:|
Husaini B, Gudlavalleti AS, Cain V, Levine R, Moonis M. Risk factors and hospitalization costs of Dementia patients: Examining race and gender variations. Indian J Community Med 2015;40:258-63
|How to cite this URL:|
Husaini B, Gudlavalleti AS, Cain V, Levine R, Moonis M. Risk factors and hospitalization costs of Dementia patients: Examining race and gender variations. Indian J Community Med [serial online] 2015 [cited 2022 May 20];40:258-63. Available from: https://www.ijcm.org.in/text.asp?2015/40/4/258/164396
| Introduction|| |
Dementia is a chronic disease characterized by progressive cognitive decline that interferes with independent functioning.  Dementia affects 5% to10% of elderly aged 65 and above,  and its prevalence varies by race and gender. Generally, the prevalence of the disease is higher in women.  Out of the 5 million individuals aged 65 and above with Alzheimer's disease, which is the most common type of dementia in the United States, 3.2 million are women. , A nationwide prevalence study found that the cumulative prevalence of dementia among elderly aged 65 and above was higher in women than in men (9.9% vs. 6.4%).  This may be due to the fact that women tend to live longer. , However, some studies suggest that socio-cultural and hormonal differences may also have a role to play. 
Studies have reported racial differences whereby black elderly were reported to have a higher prevalence of dementia compared to their white peers of the same age. ,, These differences may occur due to a higher prevalence of cardiovascular risk factors, lower levels of education, lower socio-economic status, and may not be due to genetic variation.  In another study, the racial differences were not significant when the analysis was adjusted for demographics, socioeconomic status, and co-morbidities such as stroke, hypertension, diabetes mellitus and myocardial infarction. 
The healthcare cost of dementia has risen nearly sixteen-fold, from $13.26 billion in 1988 to $214 billion in 2014. , The Alzheimer's association reported that the total per person payment from all sources of health care for Medicare beneficiaries suffering from dementia, was three times as great as payments for other Medicare beneficiaries ($46,669 vs. $14,772).  Although a large share of the expenditure seems to be associated with unpaid informal care giving,  this high out of pocket (OOP) expenditure also raises concerns. After controlling for demographics and co-morbidities, Delevande and colleagues found that dementia patients had more than three times the yearly OOP expenditure, as compared to those with normal cognition ($8216 vs. $2570). 
Racial disparities in the cost of dementia care are quite prominent. A study demonstrated that blacks had a significantly higher cost of care as compared to whites, primarily due to more frequent inpatient care and a greater severity of illness.  An analysis of Medicare beneficiaries in Tennessee demonstrated that the average Medicare costs for black patients with dementia were $4,645 higher than those for white patients.  Gender comparisons of cost of dementia, however, are scarce and require more attention.
In this study, we explore the variation in prevalence, risk factors, and cost of dementia in four race-gender cohorts of Medicare beneficiaries in Tennessee, aged 65 years and above.
| Materials and Methods|| |
Our study was approved by the Institutional Review Board of the Tennessee State University. We used Tennessee Hospital Discharge Data files on elderly patients (aged 65 and above; n = 154,945) discharged in 2008. These files were administrative files submitted for reimbursement; they provided both the primary and secondary diagnoses (ICD-9 codes for which a patient was treated), along with limited demographic such as age, race, sex. These files neither provided clinical data nor data on education, income, or occupation. The ICD-9 diagnosis was provided by the attending physician. Since the Tennessee population is largely composed of whites (82%) and blacks (16%), we used four race-gender cohorts of patients with dementia (n = 5556): White Males (WM; n = 1778), White Females (WF; n = 3069), Black Males (BM; n = 253), and Black Females (BF; n = 456).
We combined the primary and secondary diagnosis of dementia per ICD-9 codes of 290.00, 290.20, 290.40-290.42, 291.2, 294.10, 294.11, and 294.20. Secondary diagnoses of patients were used as risk factors which included hypertension (HTN), diabetes mellitus (DM), hyperlipidemia (CHOL), atrial fibrillation (AFib), congestive heart failure (CHF), myocardial infarction (MI), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), and stroke. Finally, the proportion of dementia for various race-gender cohorts was computed, and age-adjusted dementia prevalence rates (of 690.6 per 100000 elderly) were developed. They were indexed to the Year 2000 Census as per the guidelines provided by CDC for the population at risk. 
To examine the cost of care, an age-adjusted analysis was performed, first for individuals with and without dementia, and across four race-gender cohorts in individuals with dementia. Only the cost incurred during hospitalization was considered. Since all individuals in the analyses were aged 65 and above, inpatient-costs were covered by Medicare benefits under Medicare Part-A benefits for all elderly aged 65 years and above.
The prevalence of risk factors among patients with dementia across the race-gender cohorts were evaluated with Pearson Chi Square (χ2 ) and the Fisher's Exact Tests. We also used multivariate logistic regression to examine the contribution of all risk factors on dementia. The age-adjusted logistic models for each race-gender cohort separately examined the likelihood of dementia associated with each risk factor. Estimating separate equations for each race-gender cohort allowed for the effects of each risk factor to vary across all cohorts.
| Results|| |
Dementia prevalence and risk factors
The overall prevalence of dementia was 3.6% [Table 1], col. 2]. The mean age of dementia patients was 82.5 years (SD = 9.1). Black males were younger in age (78.4 ± 8.8 years) compared to other cohorts. Among discharged patients, dementia was significantly higher among blacks as compared to whites (4.2% vs 3.5%, P < 0.001, cols. 3 and 4). A greater proportion of females than males had dementia (3.9% vs 3.2%, P < 0.001, cols. 6 and 5). Among the four race-sex cohorts, dementia was significantly higher (P < 0.001) in black females (4.2%), followed by black males (4.1%), white females (3.8%) and white males (3.1%; cols. 7-10). The age-adjusted prevalence of dementia (per 100,000 population) was highest among black males (902.2), followed by black females (811.4), white males (619.9), and white females (617.5).
|Table 1: Prevalence of cardiovascular risk factors among non-dementia and dementia cohorts aged 65+|
Click here to view
While one third of all dementia patients had DM, CHD, AFib, CHD, CHF, and COPD, nearly 60% had stroke and 80% had hypertension [Table 1], col. 2]. These risk factors also varied across four cohorts. Black patients had significantly higher prevalence than whites for HTN, DM, CKD, and stroke, whereas white patients had a significantly higher prevalence of CHD [Table 1], cols. 3 and 4]. Male patients had a significantly higher prevalence of DM, CHD, CKD, AFIB, CHF, MI, COPD, and stroke [Table 1], cols. 5 and 6]. [Figure 1] shows the distribution of comorbidities according to gender. In multivariate regression modeling, six risk factors having significant odds ratios (OR) emerged predicting dementia: HTN (OR = 1.11), DM (OR=1.16), CKD (OR = 1.26), CHF (OR = 1.16), COPD (OR = 1.29), and stroke (OR = 8.54; [Table 2], col. 1). Among males, CHF (OR= 1.30) was an additional contributor [Table 2], col. 4].
|Table 2: Odd Ratios (OR) of risk factors predicting dementia in patients|
Click here to view
Dementia hospital costs
Healthcare cost is affected by a number of factors including the number and complexity of co-morbidities, number of re-admissions, and the duration of stay in the hospital. We examined these factors when comparing patients with dementia (n = 5,556) and those without dementia (n = 149,389). The dementia patients had significantly greater number of co-morbidities (3.7 vs. 2.9, P < 0.001, [Table 3], cols. 1 and 2). These co-morbidities included HTN (84% vs. 77%, P < 0.001), DM (36% vs. 32%, P < 0.001), CKD (26% vs. 17%, P < 0.001), CHF (34% vs. 25%, P < 0.001), COPD (32% vs. 28%, P < .0001), and Stroke (59% vs. 14%, P < 0.001, see [Table 1], cols. 1 and 2). In contrast to patients without dementia, dementia patients [Table 3], col. 1 and 2] had more re-admissions (2.48 vs. 1.69, P < 0.001), longer hospitalizations (17.3 days vs. 9.6 days, P < 0.001), and nearly 14% higher hospital costs in 2008 ($55,938 vs. $49,285, P < 0.001).
|Table 3: Number of co-morbidities, re- admissions, hospital days, and total hospital costs of dementia and Non-dementia patients in 2008|
Click here to view
Hospitalization costs, however, varied by race. [Table 3] (cols. 3 and 4) indicates that the cost of care for blacks was 48% higher compared to their whites peers ($78,081 vs. 52,699, P < 0.001). Blacks also had significantly more number of comorbidities, (3.9 vs. 3.65, P < 0.001), higher re-admissions (2.60 vs. 2.46, P < 0.001), and longer hospital stay (21.4 days vs. 16.7 days, P < 0.001).
With respect to gender, the cost of inpatient care for males with dementia was 22% higher than that of females ($63,264 vs. 51,718, P < 0.001). These higher costs for males appear to reflect higher costs for both white and black males who, relative to females, had more co-morbidities, and longer hospitalization (19 days vs. 16 days, P < 0.001) [Table 3], cols. 5 and 6].
| Discussion|| |
In our study, we noted that age was correlated to both stroke and dementia in that the rates of stroke and dementia increased with increasing age for all race-gender cohorts. This corroborated the well-known fact that age is a significant risk factor for both dementia and stroke. ,
Our study supports the findings of previous studies which demonstrated that dementia is more prevalent in blacks. , This may be attributable to a higher prevalence of stroke and diabetes in these individuals. , Race dependent criteria for initiating treatment for diabetes and hypertension should be considered in policies aimed to prevent neuro-cognitive disorders.
Among the risk factors associated with dementia in our study, HTN, DM, CKD, CHF, COPD and stroke, are known to be associated with initial diagnosis of dementia. ,,,,,,, Out of these, hypertension and diabetes were highly prevalent in all cohorts. Additional research is needed to examine their role in small and large vessel strokes among patients with dementia. It is plausible that repeated small vessel infarcts combined with infarcts of large vessel may contribute to dementia. In our study, the association between the cardiovascular risk factors and dementia was not robust among black males because of their smaller numbers (n = 253). These individuals are those who survived a stroke and may have had dementia as an outcome of that vascular event.  It may also be noted that there is a higher mortality among elderly males with stroke. Thus, the fewer number of surviving black males in our sample, appears to be consistent with the longevity data on Tennessee population (72.5 years).  In general, black females live longer compared to black males (76 years vs. 68.7 years).  Hence the number of black males in our sample, though small, appears to be consistent with the population data on longevity.
Patients with dementia spent approximately $55,938 for total cost of care as compared to patients without dementia, who spent $49,285. This may have been partly due to more co-morbidity, higher rates of admission and almost twice the duration of hospital stay. Further, in the dementia group, black patients tended to have significantly higher cost of care than the whites. The higher costs for blacks (black males particularly) appear due to their higher co-morbidity, higher frequency of re-admission, and longer hospitalization.
In our study, males tended to have a significantly higher cost of care than females (approx $11,000). This seems counter-intuitive since our study supported the fact that women have a higher prevalence of dementia as compared to men. This again, could partly be explained by the fact that men had greater number of co-morbidities, more number of admissions, and a longer duration of stay at the hospital. Our results are supported by past studies , which showed that in patients with dementia, women avail lesser hospital care. This may be due to the fact that they may have a lower prevalence of co-morbid conditions or it may also be due to socio-cultural reasons. These studies also showed that women tended to avail more long term care than men. Since our study was not designed to analyze long term care, we were unable to address the issue. Further research addressing the differences in short -term and long -term care is required.
Finally, hypertension and diabetes appeared consistently as significant risk factors across all race and gender cohorts, and since both DM and HTN are amenable to effective management, our findings point to the need for aggressive primary and secondary prevention strategies which may reduce hospitalization costs for both stroke and dementia among the elderly.
Our study has a few limitations. This was a hospital based study and hence the findings cannot be generalized to the entire community. The diagnostic criteria used for dementia was ICD-9. After the publication of ICD-10 and DSM-5, the prevalence of dementia, and hence the cost of care, might have changed. Lastly, the study looked at only the cost for short-term inpatient care and not at the care given to these individuals in the community. The total cost of care is bound to be higher than what we found in our study.
In summary, our study demonstrated a significant race-gender disparity in prevalence of dementia and the related cost of care. Special focus needs to be given in prevention and management of modifiable risk factors such as hypertension and diabetes, which are highly prevalent in the black population. Race and gender dependent milestones for management of these risk factors should be considered. Further, insurance coverage for hospitalization could be tailored to ensure that those being admitted frequently or for a longer duration would be adequately covered by insurance services. Further research into the community based cost differences in dementia amongst race and gender cohorts, would broaden our understanding about the disparities in total cost of care across race and gender, in individuals suffering from dementia.
| References|| |
Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM. Monetary costs of dementia in the United States. N Engl J Med 2013;368:1326-34.
Husaini B, Cain V, Novotny M, Samad Z, Levine R, Moonis M. Variation in risk factors of dementia among four elderly patient cohorts. World J Neurol 2014;4:7-11.
Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer′s disease: Assessing sex and gender differences. Clin Epidemiol 2014;6:37-48.
Bennett S, Grant MM, Aldred S. Oxidative stress in vascular dementia and Alzheimer′s disease: A common pathology. J Alzheimers Dis 2009;17:245-57.
Koller D, Bynum JP. Dementia in the USA: State variation in prevalence. J Public Health (Oxf) 2014. [Epub ahead of print].
Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, et al
. Lifetime risk of dementia and Alzheimer′s disease. The impact of mortality on risk estimates in the Framingham Study. Neurology 1997;49:1498-504.
Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer′s disease greater for women than for men? Am J Epidemiol 2001;153:132-6.
Yaffe K, Falvey C, Harris TB, Newman A, Satterfield S, Koster A, et al
.; Health ABC Study. Effect of socioeconomic disparities on incidence of dementia among biracial older adults: Prospective study. BMJ 2013;347:f7051.
Dilworth-Anderson P, Hendrie HC, Manly JJ, Khachaturian AS, Fazio S; Social, Behavioral and Diversity Research Workgroup of the Alzheimer′s Association. Diagnosis and assessment of Alzheimer′s disease in diverse populations. Alzheimers Dement 2008;4:305-9.
Manly J, Mayeux R. Ethnic differences in dementia and Alzheimer′s disease. In: Anderson N, Bulatao R, Cohen B, editors. Critical Perspectives on Racial and Ethnic Differentials in Health in Late Life. Washington, DC.: National Academies Press; 2004. p. 95-141.
Huang LF, Cartwright WS, Hu TW. The economic cost of senile dementia in the United States, 1985. Public Health Rep 1988;103:3-7.
Langa KM, Chernew ME, Kabeto MU, Herzog AR, Ofstedal MB, Willis RJ, et al
. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med 2001;16:770-8.
Delevande A, Hurd MD, Martorell P, Langa KM. Dementia and out-of pocket spending on health care services. Alzheimers Dement 2013;9:19-29.
Husaini BA, Sherkat DE, Moonis M, Levine R, Holzer C, Cain VA. Racial differences in the diagnosis of dementia and in its effects on the use and costs of health care services. Psychiatr Serv 2003;54:92-6.
Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Stat Notes 2001;1-10.
Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, et al
. American heart association prevention conference. iv. prevention and rehabilitation of stroke. Risk factors. Stroke 1997;28:1507-17.
Sheinart KF, Tuhrim S, Horowitz DR, Weinberger J, Goldman M, Godbold JH. Stroke recurrence is more frequent in Blacks and Hispanics. Neuroepidemiology 1998;17:188-98.
Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam study. Neurology 1999;53:1937-42.
Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H, et al
. Vascular risk factors are associated with faster decline of Alzheimer disease: A longitudinal SPECT study. J Neurol 2011;258:1295-303.
Rastas S, Pirttilä T, Mattila K, Verkkoniemi A, Juva K, Niinistö L, et al
. Vascular risk factors and dementia in the general population aged and >85 years: Prospective population-based study. Neurobiol Aging 2010;31:1-7.
Ligthart SA, Moll van Charante EP, Van Gool WA, Richard E. Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: A systematic review. Vasc Health Risk Manag 2010;6:775-85.
Savva GM, Stephan BC; Alzheimer′s Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia: A systematic review. Stroke 2010;41:e41-6.
Khoury JC, Kleindorfer D, Alwell K, Moomaw CJ, Woo D, Adeoye O, et al
. Diabetes mellitus: A risk factor for ischemic stroke in a large biracial population. Stroke 2013;44:1500-4.
Flicker L. Cardiovascular risk factors, cerebrovascular disease burden, and healthy brain aging. Clin Geriatr Med 2010;26: 17-27.
Schwarzkopf L, Menn P, Leidl R, Wunder S, Mehlig H, Marx P, et al
. Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data. BMC Health Serv Res 2012;12:165.
Forma L, Rissanen P, Aaltonen M, Raitanen J, Jylhä M. Dementia as a determinant of social and health service use in the last two years of life 1996-2003. BMC Geriatr 2011; 11:14.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Disparities in Physical and Psychological Symptoms in Hospitalized African American and White Persons with Dementia
| ||Marie Boltz, Rhonda BeLue, Barbara Resnick, Ashley Kuzmik, Elizabeth Galik, Joanne R. Jones, Rachel Arendacs, Liron Sinvani, Jacqueline Mogle, James E. Galvin |
| ||Journal of Aging and Health. 2021; 33(5-6): 340 |
|[Pubmed] | [DOI]|
||Ten-year trends in hospitalizations due to Alzheimer’s disease in Brazil: a national-based study
| ||Natan Feter, Jayne Santos Leite, Samuel Carvalho Dumith, Airton José Rombaldi |
| ||Cadernos de Saúde Pública. 2021; 37(8) |
|[Pubmed] | [DOI]|
||The Excess Costs of Dementia: A Systematic Review and Meta-Analysis
| ||Nadine Sontheimer, Alexander Konnopka, Hans-Helmut König |
| ||Journal of Alzheimer's Disease. 2021; 83(1): 333 |
|[Pubmed] | [DOI]|
||Access to Health Services in Older Minority Ethnic Groups with Dementia: A Systematic Review
| ||Melissa Co,Elyse Couch,Qian Gao,Scarlett Mac-Ginty,Jayati Das-Munshi,Matthew Prina |
| ||Journal of the American Geriatrics Society. 2020; |
|[Pubmed] | [DOI]|
||Hospital Disparities between Native Hawaiian and Other Pacific Islanders and Non-Hispanic Whites with Alzheimer’s Disease and Related Dementias
| ||Andrea H. Hermosura,Carolyn J. Noonan,Amber L. Fyfe-Johnson,Todd B. Seto,Joseph K. Kaholokula,Richard F. MacLehose |
| ||Journal of Aging and Health. 2020; 32(10): 1579 |
|[Pubmed] | [DOI]|